Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity?
JAMA Intern Med
.
2023 Jun 1;183(6):532-533.
doi: 10.1001/jamainternmed.2023.0625.
Authors
Richard C Becker
1
,
Thomas L Ortel
2
Affiliations
1
University of Cincinnati Heart, Lung, and Vascular Institute, Cincinnati, Ohio.
2
Departments of Medicine and Pathology, Division of Hematology, Duke University Medical Center, Durham, North Carolina.
PMID:
36946227
DOI:
10.1001/jamainternmed.2023.0625
No abstract available
Publication types
Comment
MeSH terms
Anticoagulants / pharmacology
Anticoagulants / therapeutic use
Blood Coagulation
COVID-19*
Humans
SARS-CoV-2
Substances
Anticoagulants